Drug absorption and first pass metabolism Flashcards

1
Q

What are the rate limiting steps for oral absorption?

A

Movement through membranes

a) perfusion OR
b) permeability limitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the transcellular route ?

A

Through the cell via passive diffusion, active transport (e.g. PEPT1) or facillitated transport

  • follows concentration gradient
  • transport continues until equilibrium is reached
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does transcellular transport depend on?

A
  • lipophilicity – more lipophilic more permeable
  • molecular size –
  • degree of ionisation (slow movement for large, polar and charged molecules)
  • molecular structure – H-donor/acceptor, functional groups
  • surface area available – varies along the gut
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the paracellular route?

A

Transport between epithelial cells:

  • mainly via passive diffusion
  • important for polar hyrdophilic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the paracellular route dependent on?

A
  • molecular size
  • size and density of junctions
  • surface area
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is P-gp and where is it found?

A

Efflux transporter located on the apical membrane of enterocytes, biliary canalicular membrane of hepatocytes and other tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What effect does P-gp have on bioavailability?

A

P-gp decreases concentration of drugs and metabolites in the enterocytes via active efflux into intestinal lumen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the P-glycoprotein-CYP3A4 interplay?

A

Drugs are metabolised by CYP3A4 enzymes and the metabolite is effluxed by P-gp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does the P-glycoprotein-CYP3A4 interplay lead to?

A
  • Recirculation of the drug
  • Increased exposure to CYP3A4
  • Generally leads to low F (e.g. saquinavir, atorvastatin)
  • Inter-individual variability in drug absorption and F
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can movement of drug across the membrane be rate limited by?

A

Either perfusion or permeability

Slowest process = rate limiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is perfusion?

A
  • Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue.
  • Membrane offers no effective barrier to drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What sort of molecules have good perfusion?

A

Small lipophilic molecules (many drugs) and very small hydrophilic molecules readily passes across membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What varies absorption of drug via perfusion?

A

Blood flow (rate limitation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is permeability limited absorption?

A

When a molecule has difficulty passing across membrane - poor permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What types of molecules have poor permeability?

A

Large polar hydrophilic molecules (most newly developed drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Does blood flow affect permeation absorption?

A

NO - Absorption insensitive to changes in blood flow

17
Q

Does the permeability of intestinal wall membrane change along the GIT?

A

YES - changes in permeability along GIT will affect rate limitation.

Expression of metabolic enzymes also varies

18
Q

Are poorly permeable drugs good candidates for extended release formulations?

A

NO

19
Q

What drugs show low oral bioavailability (examples)?

A
  • Amikacin
  • Gentamicin
  • Vancomycin
  • Neomycin
  • Streptomycin
    etc
20
Q

Bioavailability equation for first pass metabolism?

A

F = Fa.Fg.Fh
Fa - fraction absorbed through the membrane into the enterocyte)

Fg - Fraction escaping intestinal metabolism

Fh - Fraction escaping hepatic metabolism

21
Q

A drug has an Fg value of 0.15. What can be deduced about its 1st pass from this information?

A

pronounced intestinal first pass (lower the value the lower the amount that is escaping first pass) only 15% is escaping intestinal metabolism
–> Therefore the drug would have low bioavailability

22
Q

What does extensive metabolism in enterocytes result in ?

A

Low Fg (intestinal metabolism) - and therefore contributing to low F

23
Q

What does the inhibition of intestinal enzymes and transporters contribute to?

A

DDIs reported for many drugs

24
Q

What food/drink selectively inhibits intestinal CYP3A4?

A

Grapefruit juice (irreversible inhibitors), with no effect on hepatic CYP3A4

25
Q

What can co-administration of grapefruit juice and CYP3A4 substrates (e.g. statins) do?

A
  • prevent metabolism and elimination of the ‘victim’ drug
  • Increase plasma concentrations (Cmax) of the ‘victim drug’
  • hence why it’s recommended to NOT take with some statins
26
Q

What are some examples of drugs with low oral bioavailability due to extensive first pass metabolism?

A
  • saquinavir
  • felodipine
  • simvastatin
  • atorvastatin
  • lovastatin
  • rifabutin
  • cyclosporine
  • tacrolimus
  • sildenafil
  • verapamil
  • diltiazem
27
Q

What formulation gives higher F of drugs with extensive intestinal 1st pass?

A

MR e.g. oxybutynin

28
Q

What is the nature of the muscle capillary membrane in IM/Sc absorption?

A
  • Nature of barrier different to the gut wall - membrane is more porous, drugs more readily absorbed via paracellular route
  • generally perfusion rate limited
29
Q

What is pulmonary absorption

A
  • important for inhalers and treatment of respiratory diseases (asthma, COPD)
  • rapid access to systemic circulation due to large SA of lungs
30
Q

What is an advantage of pulmonary absorption?

A

Avoids first pass metabolism

31
Q

What is a disadvantage of pulmonary absorption?

A

commonly only 2-10 % aerosol dose deposited in lungs, 90% dose is swallowed!